The outbreak of COVID-19 brought the mRNA technology to light. From a silent long-term technology that needed to prove its potential, well behind other technologies like C&G therapies, to the focus of everyone's attention. Lead by Moderna, BioNTech and CureVac the number of players in this field is growing rapidly. New starts-up as well as establish pharmaceutical companies are now turning to mRNA. What are the exciting applications for mRNA technology beyond the COVID-19 vaccine? The goal of this session is to explore the potential of mRNA applications from vaccines to personalized medicines and beyond as a catalysator for such transformation.